Product description
Fertibiome® is an innovative probiotic solution specifically designed
to reverse urogenital dysbiosis in couples and improve reproductive health. It is formulated with the exclusive patented strain
Ligilactobacillus salivarius PS11610 and is supported by a clinical trial that achieved the following results:
-
Significant reduction of pathogenic bacteria after 3 and 6 months of treatment.
-
Restoration of microbial balance in the male and female urogenital tract.
-
Improvement of uterine immune status by reducing inflammation.
Additionally, the first published retrospective study evaluated the impact of the Fertibiome® probiotic strain
Ligilactobacillus salivarius PS11610 on in vitro fertilization (IVF) treatment outcomes. The study demonstrated an improvement in IVF success rates with frozen embryo transfers. Currently, the second clinical trial has been published with results that support the efficacy of Fertibiome®.
Fertibiome® supplementation is a promising tool in assisted reproduction treatments, improving pregnancy outcomes and live birth rates.
Read more